A subscription to JoVE is required to view this content. Sign in or start your free trial.
This manuscript describes two radiotracer administration protocols for FDG-PET (constant infusion and bolus plus infusion) and compares them to bolus administration. Temporal resolutions of 16 s are achievable using these protocols.
Functional positron emission tomography (fPET) provides a method to track molecular targets in the human brain. With a radioactively-labelled glucose analogue, 18F-fluordeoxyglucose (FDG-fPET), it is now possible to measure the dynamics of glucose metabolism with temporal resolutions approaching those of functional magnetic resonance imaging (fMRI). This direct measure of glucose uptake has enormous potential for understanding normal and abnormal brain function and probing the effects of metabolic and neurodegenerative diseases. Further, new advances in hybrid MR-PET hardware make it possible to capture fluctuations in glucose and blood oxygenation simultaneously using fMRI and FDG-fPET.
The temporal resolution and signal-to-noise of the FDG-fPET images is critically dependent upon the administration of the radiotracer. This work presents two alternative continuous infusion protocols and compares them to a traditional bolus approach. It presents a method for acquiring blood samples, time-locking PET, MRI, experimental stimulus, and administering the non-traditional tracer delivery. Using a visual stimulus, the protocol results show cortical maps of the glucose-response to external stimuli on an individual level with a temporal resolution of 16 s.
Positron emission tomography (PET) is a powerful molecular imaging technique that is widely used in both clinical and research settings (see Heurling et al.1 for a recent comprehensive review). The molecular targets that can be imaged using PET are only limited by the availability of radiotracers, and numerous tracers have been developed to image neural metabolism receptors, proteins, and enzymes2,3. In neuroscience, one of the most used radiotracers is 18F-fluorodeoxyglucose (FDG-PET), which measures glucose uptake, usually interpreted as an index of cerebral glucose metabol....
This protocol has been reviewed and approved by the Monash University Human Research Ethics Committee (approval number CF16/1108 - 2016000590) in accordance with the Australian National Statement on Ethical Conduct in Human Research24. Procedures were developed under the guidance of an accredited Medical Physicist, Nuclear Medicine Technologist, and clinical radiographer. Researchers should refer to their local experts and guidelines for the administration of ionizing radiation in humans.
Study-specific methods
Here, study-specific details for the representative results are reported. These details are not critical to the procedure and will vary across studies.
Participants and task design
Participants (n = 3, Table 2) underwent a simultaneous BOLD-fMRI/FDG-fPET study. As this manuscript focuses on the PET acquisition protocol, MRI re.......
FDG-PET is a powerful imaging technology that measures glucose uptake, an index of cerebral glucose metabolism. To date, most neuroscience studies using FDG-PET use a traditional bolus administration approach, with a static image resolution that represents the integral of all metabolic activity over the course of the scan2. This manuscript describes two alternative radiotracer administration protocols: the infusion-only (e.g., Villien et al., Jamadar et al.19,
Jamadar is supported by an Australian Council for Research (ARC) Discovery Early Career Researcher Award (DECRA DE150100406). Jamadar, Ward, and Egan are supported by the ARC Centre of Excellence for Integrative Brain Function (CE114100007). Chen and Li are supported by funding from the Reignwood Cultural Foundation.
Jamadar, Ward, Carey, and McIntyre designed the protocol. Carey, McIntyre, Sasan, and Fallon collected the data. Jamadar, Ward, Parkes, and Sasan analyzed the data. Jamadar, Ward, Carey, and McIntyre wrote the first draft of the manuscript. All authors have reviewed and approved the final version.
....Name | Company | Catalog Number | Comments |
Blood Collection Equipment | |||
--12-15 vacutainers | Becton Dickinson, NJ USA | 364880 | Remain in sterile packaging until required to put blood in tube |
--12-15 10mL LH blood collecting tubes | Becton Dickinson | 367526 | Marked with the sample number (e.g., S1, S2…) and subsequently marked with the sample time (e.g., time 0 + x min [T0+x]) |
--2-15 10mL Terumo syringe | Terumo Tokyo, Japan | SS+10L | These are drawn up on the day of the study and capped with the ampoule that contained the saline |
-- pre-drawn 0.9% saline flushes | Pfizer, NY, USA | 61039117 | |
--12-15 5mL Terumo syringes | Terumo Tokyo, Japan | SS+05S | Remain in sterile packaging until ready to withdraw a blood sample |
Safety & Waste Equipment | All objects arranged on a plastic chair inside the scanner room on the same side as the arm from which the blood samples will be taken. Biohazard and non-biohazard waste bags to be used. Gloves and waste bags to be easily accessible when preparing the radioactivity in the dispensing area and when pipetting the plasma samples. Biohazard and non-biohazard waste bags to be used. All waste generated is checked with the Geiger counter to ensure that radioactive contaminated waste is stored until it is safe to be disposed of according to Australian Radiation Protection and Nuclear Safety Agency (APRANSA) guidelines for Radiation protection series No.6 (2017). | ||
-- Gloves | Westlab, VIC, Australia | 663-219 | |
-- waste bags | Austar Packaging, VIC, Australia | YIW6090 | |
--cello underpads ‘blueys’ Underpads 5 Ply | Halyard Health, NSW, Australia | 2765A | |
--Blue Sharpie pen | Sharpie, TN, USA | S30063 | |
Dose Syringes | Remain in sterile packaging until ready for use. All syringes used in this facility have an additional 20% volume capacity above the stated volume on the packaging. This is important for the 50mL syringe where the total capacity of 60mL is used | ||
--5mL | Terumo Tokyo, Japan | SS+05S | |
-- 20mL | Terumo Tokyo, Japan | SS+20L | |
--50mL | Terumo Tokyo, Japan | SS*50LE | |
--1 Terumo 18-gauge needle | Terumo Tokyo, Japan | NN+1838R | Remain in sterile packaging until ready to inject [18F]FDG into the saline bag |
--100mL 0.9% saline bag | Baxter Pharmaceutical, IL, USA | AHB1307 | Remain in sterile packaging until ready to inject [18F]FDG |
Radiochemistry Lab Supplies | |||
--Heraeus Megafuge 16 centrifuge; Rotor Bioshield 720 | ThermoScientific MA, USA | 75004230 | Relative Centrifugal Force = 724 Our settings are 2000RPM for 5mins. Acceleration and deceleration curves set to 8 |
--Single well counter | Laboratory Technologies, Inc. IL, USA | 630-365-1000 | Complete daily quality control (includes background count) and protocol set to 18F and 4mins. Cross calibration is performed between the well counter, dose calibrator and scanner on a bi-monthly basis. |
--Pipette | ISG Xacto, Vienna, Austria | LI10434 | We use a 100-1000 μL set to 1000μL. It is calibrated annually. |
--12-15 plasma counting tubes | Techno PLAS; SA Australia | P10316SU | Marked in the same manner as the LH blood tubes |
--12-15 pipette tips | Expell Capp, Denmark | 5130140-1 | |
--3 test tube racks | Generic | Checked with a Geiger counter to ensure there is no radiation contamination on them | |
--500mL volumetric flask and distilled water | Generic | Need approximately 500mL of distilled water to prepare the reference for gamma counting | |
--Synchronised clocks in scanner room, console and radiochemistry lab | Generic | Synchronisation checks are routinely completed in the facility on a weekly basis | |
--Haemoglobin Monitor | EKF Diagnostic Cardiff, UK Haemo Control. | 3000-0810-6801 | Manufacturer recommended quality control performed before testing on participant’s blood sample. |
--Glucometre | Roche Accu-Chek | 6870252001 | Accu-Chek Performa is used to measure participant blood sugar levels in mmol/L. Quality control is performed daily using high and low concentration solution control test. |
Cannulating Equipment | Check expiry dates and train NMT to prepare aseptically for cannulation. | ||
--Regulation tourniquet | CBC Classic Kimetec GmBH | K5020 | |
--20, 22 and 24 gauge cannulas | Braun, Melsungen Germany | 4251644-03; 4251628-03; 4251601-03 | |
--tegaderm dressings | 3M, MN USA | 1624W | |
--alcohol and chlorhexidine swabs | Reynard Health Supplies, NSW Australia | RHS408 | |
--0.9% saline 10mL ampoules; for flushes | Pfizer, NY, USA | 61039117 | |
--10mL syringes | Terumo Tokyo, Japan | SS+10L | |
--3-way tap | Becton Dickinson Connecta | 394600 | |
--IV bung | Safsite Braun PA USA | 415068 | |
--Optional extension tube, microbore extension set | M Devices, Denmark | IV054000 | |
Scanner Room Equipment | |||
--Siemens Biograph 3T mMR | Siemens, Erlangen, Germany | ||
--Portable lead barrier shield | Gammasonics | Custom-built | MR-conditional lead barrier shield. Positioned at the 2000 Gauss line with the castors locked to provide additional shielding of the radioactivity connected to the infusion pump. |
--Infusion pump BodyGuard 323 MR-conditional infusion pump | Caesarea Medical Electronics | 300-040XP | MR-compatible. This model is cleared for use on 1.5 and 3T scanners at 2000 Gauss with castors locked. |
--Infusion pump tubing | Caesarea Medical Electronics | 100-163X2YNKS | Tubing is administration set with an anti-siphon valve and male luer lock (REF 100-163X2YNKS). |
--Lead bricks | Custom built | Tested for ferromagnetic translational force | |
Other Equipment | |||
--Syringe shields | Biodex, NY USA | Custom-built | There is a 5mL tungsten syringe shield that is MR-safe, as well as a 50mL lead shield that has been tested for ferromagnetic attraction prior to use in the MR-PET scanner. It is used to transport the radioactive dose from the radiochemistry lab into the scanner to minimise radiation exposure to the NMT. |
--Geiger counter Model 26-1 Integrated Frisker | Ludlum Measurements, Inc. TX USA | 48-4007 | This is calibrated annually and used to monitor potential contamination and waste. It is not taken into the MR-PET scanner. |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved